BFM
GSK icon

Boothbay Fund Management’s GSK GSK Stock Holding History

Boothbay Fund Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-59,200
Closed -$2.42M – 1665
2024
Q3 		$2.42M Buy
+59,200
New +$2.42M 0.06% 459
2023
Q2 		– Sell
-37,000
Closed -$1.32M – 1994
2023
Q1 		$1.32M Sell
37,000
-337,500
-90% -$11.8M 0.03% 878
2022
Q4 		$13.2M Buy
374,500
+165,200
+79% +$5.5M 0.3% 35
2022
Q3 		$6.16M Buy
+209,300
New +$7.93M 0.15% 134

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Boothbay Fund Management's GSK Position: Q3 2025 in Review

Boothbay Fund Management sold out of GSK (GSK) in Q3 2025, closing a stake of 20,000 shares — an estimated $768K sold.

Boothbay Fund Management first reported a position in GSK in Q3 2021 and held it in 11 quarters. The position peaked at $29.7M in Q2 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Boothbay Fund Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 20,000 GSK shares in Q3 2025, an estimated $768K.
  • Boothbay Fund Management first reported a position in GSK in Q3 2021 and held it in 11 quarters.
  • Boothbay Fund Management's GSK position peaked at $29.7M in Q2 2023.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.